Our team.

Dr. Azim is a practicing medical oncologist and a clinical development consultant for EU and US oncology biotechs having served before as chief medical officer at Emergence Therapeutics and Vice President/Head of clinical development at Innate Pharma in France. He is also a senior medical oncologist at Cairo Cure Oncology Center and Senior Faculty at the College of the European School of Oncology. He holds a Master's Degree in Oncology from University of Newcastle Upon Tyne (UK) and PhD from the Université Libre de Bruxelles (Belgium). Dr. Azim completed his oncology training at the National Cancer Institute in Cairo and the European Institute of Oncology in Milan. He then completed his breast cancer fellowship at the Institut Jules Bordet in Brussels before serving as scientific director for the breast cancer research unit for three years at the same institution.

Matteo Oldani is a Strategic CFO at Rosetta Omics, supporting the company's mission to advance cancer precision medicine through multi-omics profiling and AI. He is Associate Partner at YOURgroup, Italy's leading C-Level Executive group, and a member of ANDAF. He specializes in finance, sustainability, organizational transformation and strategy. Matteo holds an Executive MBA from ESCP, the CFA Certificate in Sustainable Investing, and is certified in Neuro-Linguistic Programming (NLP).

Noah Sultan is a data science expert with a PhD in machine learning and more than 10 years of experience in AI and ML. His career began in academia, where he developed DNA motif discovery software at the French National Institute for Agriculture, Food and the Environment. Since then, he has designed and built multiple AI solutions end-to-end, including backend, frontend, deployment, hosting, and tracking. With professional experience across France, Germany, Italy, and Egypt, he brings a global perspective and adaptability to every project.